Location · Surprise, AZ
Clinical trials in Surprise, AZ
9 recruiting studies have a site in Surprise, and 0 of them accept healthy volunteers.
9 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Takeda
- Location
- Surprise, AZ + 42 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Sanofi
- Location
- Surprise, AZ + 72 other US sites
- Eligibility basics
- Ages 40–80
- Recruiting
Renal Pelvic Denervation Pilot Trial
Verve Medical, Inc
- Location
- Surprise, AZ + 7 other US sites
- Eligibility basics
- Ages 21–80
- RecruitingPhase 3
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Boehringer Ingelheim
- Location
- Surprise, AZ + 55 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 4
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Amgen
- Location
- Surprise, AZ + 57 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingPhase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
AstraZeneca
- Location
- Surprise, AZ + 104 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Eli Lilly and Company
- Location
- Surprise, AZ + 120 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
AstraZeneca
- Location
- Surprise, AZ + 9 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 2/Phase 3
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Vertex Pharmaceuticals Incorporated
- Location
- Surprise, AZ + 26 other US sites
- Eligibility basics
- Ages 18–75